Blocking central galanin receptors attenuates insulin sensitivity in myocytes of diabetic trained rats

Journal of Neuroscience Research

Volumn 91, Issue 7, 2013, Pages 971-977

  Bu, Le ^a   Liu, Zhimin ^b   Zou, Junjie ^b   Gao, Xiang ^b   Bao, Yi ^b   Qu, Shen ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Galanin receptors; Insulin sensitivity; Intracerebroventricular injection; Myocytes

Indexed keywords

GALANIN; GALANIN DERIVATIVE; GALANIN RECEPTOR; GALANIN[1-13]BRADYKININ[2-9]AMIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN SENSITIZING AGENT; M 35; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CELL LEVEL; CELL MEMBRANE; CELL SURFACE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; DIABETES CONTROL; GENE EXPRESSION REGULATION; GLUCOSE CLAMP TECHNIQUE; HYPOTHALAMUS; INSULIN SENSITIVITY; MALE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; SKELETAL MUSCLE; TREADMILL;

ANIMALS; BRADYKININ; CELL MEMBRANE; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; EXERCISE TEST; GALANIN; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; LOCOMOTION; MALE; MUSCLE CELLS; PEPTIDE FRAGMENTS; PPAR ALPHA; RATS; RATS, WISTAR; RECEPTORS, GALANIN; RNA, MESSENGER; STREPTOZOCIN; TRITIUM;

EID: 84877926889     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23228     Document Type: Article

References (27)

1. Abete I, Goyenechea E, Zulet MA, Martínez JA. 2011. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 21:B1-B15.
2. Atalik KE, Okudan N, Gokbel H, Kalkan S, Cuce G. 2010. Diabetes mellitus- and cooling-induced bladder contraction: an in vitro study. J Smooth Muscle Res 46:175-183.
3. Ciosek J, Cisowska A. 2003. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats. J Physiol Pharmacol 54:625-641.
4. Díaz-Cabiale Z, Parrado C, Rivera A, de la Calle A, Agnati L, Fuxe K, Narváez JA. 2007. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype. Neuropharmacology 52:684-692.
5. Fang PH, Yu M, Ma YP, Li J, Sui YM, Shi MY. 2011. Central nervous system regulation of food intake and energy expenditure: role of galanin-mediated feeding behavior. Neurosci Bull 27:407-412.
6. Finck BN, Bernal-Mizrachi C, Han DH, Coleman T, Sambandam N, LaRiviere LL, Holloszy JO, Semenkovich CF, Kelly DP. 2005. A potential link between muscle peroxisome proliferator-activated receptor-α signaling and obesity-related diabetes. Cell Metab 1:133-144.
7. Flanagan DE, Vaile JC, Petley GW, Phillips DI, Godsland IF, Owens P, Moore VM, Cockington RA, Robinson JS. 2007. Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system. Regul Pept 140:37-42.
8. Geiger PC, Han DH, Wright DC, Holloszy JO. 2006. How muscle insulin sensitivity is regulated: testing of a hypothesis. Am J Physiol Endocrinol Metab 291:E1258-E1263.
9. Guo L, Shi M, Zhang L, Li G, Zhang L, Shao H, Li J, Fang P, Ma Y, Shi Q, Sui Y. 2011. Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats. Gen Comp Endocrinol 173:159-163.
10. Hajhashemi V, Sadeghi H, Minaiyan M, Movahedian A, Talebi A. 2010. The role of central mechanisms in the anti-inflammatory effect of amitriptyline on carrageenan-induced paw edema in rats. Clinics (Sao Paulo) 65:1183-1187.
11. He B, Shi M, Zhang L, Li G, Zhang L, Shao H, Li J, Fang P, Ma Y, Shi Q, Sui Y. 2011. Beneficial effect of Galanin on insulin sensitivity in muscle of type 2 diabetic rats. Physiol Behav 103:284-289.
12. Holmes PV, Yoo HS, Dishman RK. 2006. Voluntary exercise and clomipramine treatment elevate prepro- galanin mRNA levels in the locus coeruleus in rats. Neurosci Lett 408:1-4.
13. Jiang L, Shi M, Guo L, He B, Li G, Zhang L, Zhang L, Shao H. 2009. Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle. Neurosci Lett 467:178-181.
14. Klenerova V, Flegel M, Skopek P, Sida P, Hynie S. 2011. Galanin modulating effect on restraint stress-induced short- and long-term behavioral changes in Wistar rats. Neurosci Lett 502:147-151.
15. Lahaye Sle D, Gratas-Delamarche A, Malardé L, Vincent S, Zguira MS, Morel SL, Delamarche P, Zouhal H, Carré F, Bekono FR. 2010. Intense exercise training induces adaptation in expression and responsiveness of cardiac β-adrenoceptors in diabetic rats. Cardiovasc Diabetol 9:72-77.
16. Leney SE, Tavaré JM. 2009. The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol 203:1-18.
17. Liang Y, Sheng SD, Fang PH, Ma YP, Li J, Shi QJ, Sui YM, Shi MY. 2012. Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats. Pharmacol Biochem Behav 100:554-559.
18. Murray PS, Groves JL, Pettett BJ, Britton SL, Koch LG, Dishman RK, Holmes PV. 2010. Locus coeruleus galanin expression is enhanced after exercise in rats selectively bred for high capacity for aerobic activity. Peptides 31:2264-2268.
19. Nagase H, Nakajima A, Sekihara H, York DA, Bray GA. 2002. Regulation of feeding behavior, gastric emptying, and sympathetic nerve activity to interscapular brown adipose tissue by galanin and enterostatin: the involvement of vagal-central nervous system interactions. J Gastroenterol 37:118-127.
20. Olson AL, Liu ML, Moye-Rowley WS, Buse JB, Bell GI, Pessin JE. 1993. Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J Biol Chem 268:9839-9846.
21. Robinson E, Grieve DJ. 2009. Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease. Pharmacol Ther 122:246-263.
22. Shan WF, Chen BQ, Zhu SJ, Jiang L, Zhou YF. 2011. Effects of GLUT4 expression on insulin resistance in patients with advanced liver cirrhosis. J Zhejiang Univ Sci B 12:677-682.
23. Van Hoomissen JD, Holmes PV, Zellner AS, Poudevigne A, Dishman RK. 2004. Effects of beta-adrenoreceptor blockade during chronic exercise on contextual fear conditioning and mRNA for galanin and brain-derived neurotrophic factor. Behav Neurosci 118:1378-1390.
24. Vijayakumar MV, Ajay AK, Bha MK. 2010. Demonstration of a visual cell-based assay for screening glucose transporter 4 translocation modulators in real time. J Biosci 35:525-531.
25. Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump C, Ferrario C, Sowers JR. 2007. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab 293:E355-E363.
26. Whitelaw CM, Robinson JE, Chambers GB, Hastie P, Padmanabhan V, Thompson RC, Evans NP. 2009. Expression of mRNA for galanin, galanin-like peptide and galanin receptors 1-3 in the ovine hypothalamus and pituitary gland: effects of age and gender. Reproduction 137:141-150.
27. Yoshitake T, Yoshitake S, Savage S, Elvander-Tottie E, Ogren SO, Kehr J. 2011. Galanin differentially regulates acetylcholine release in ventral and dorsal hippocampus: a microdialysis study in awake rat. Neuroscience 197:172-180.